SCHMC

Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer

Metadata Downloads
All Author(s)
S. C. Lee ; K. Lee ; S. B. Bae ; H. J. Kim ; S. Y. Oh ; S. Y. Song ; D. S. Hong ; J. Yoon ; D. H. Lim ; S. I. Lee ; J. H. Won ; N. Lee ; K. Kim ; H. W. Lee ; H. R. Lee ; E. M. Nam ; J. S. Jang ; I. G. Hwang ; J. H. Kang
Intsitutional Author(s)
이상철; 이규택; 배상병; 김한조
Issued Date
2015
Type
Conference
Conference Name
European Cancer Congress 2015
Conference Date
42272
dc_citation_conferenceCountry
Austria
Citation Publisher
ECCO
ESMO
ESTRO
ESSO
EACR
EONS
SIOPE
Citation Title
European Journal of Cancer
Citation Start Page
S456
Citation End Page
S456
Language(ISO)
eng
DOI
10.1016/S0959-8049(16)31277-1
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/4367
Appears in Collections:
종양혈액내과 > 2. Conference Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.